Paul W. Collins

Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors:  Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)

Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw et al. · Journal of Medicinal Chemistry · 1997 · 2K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2

Ish Khanna, Richard M. Weier, Yi Yu et al. · Journal of Medicinal Chemistry · 1997 · 169 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organization

Michael Laffan, Simon Brown, Paul W. Collins et al. · Haemophilia · 2004 · 165 citations

Medicine, Hematology, Hemostasis +14

Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors

Jeffery S. Carter, Steven W. Kramer, John J. Talley et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 158 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

John Pasi, Paul W. Collins, David Keeling et al. · Haemophilia · 2004 · 138 citations · Full text

Medicine, Hematology, Hematology Physiology +16